Advize Health
  • About Us
  • Solutions
    • For Payers
    • For Legal
    • For Doctors & Hospitals
    • For Federal
    • Risk Adjustment Integrity Group
  • Resources
    • Case Studies
    • Blog
  • Contact
Select Page
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence

How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence

by Advize Admin | Jul 8, 2022 | COVID19, Healthcare

The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as covid-19 continues to infect tens of thousands of people and kill hundreds each day. Its success in...

Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales

by Erik Consorsha | Jul 30, 2021 | Healthcare

Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs. By making prohibitively expensive medicine essentially...

Recent Posts

  • Big Pharma Went All In to Kill Drug Pricing Negotiations
  • Inflation Reduction Act Contains Important Cost-Saving Changes for Many Patients — Maybe for You 
  • OIG Files: Vignettes of the Week
  • Come Fly with OIG
  • Dollar For in the News

Recent Comments

    Advize Health, LLC products and services are in compliance with Section 508 Standards. Section 508 of the Rehabilitation Act, as amended by the Workforce Investment Act of 1998 (P.L. 105-220) and Section 508 accessibility standards at 36 CFR 1194.

    © 2022 Advize Health LLC